Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Industry news
RSS Feeds
Search

PR Newswire

News of the day

MedicalBillersandCoders.com Launches a Job Board for Medical Billing and Coding Professionals Across all 50 US States

23rd May 2012 WILMINGTON, Delaware, May 23, 2012 /PRNewswire/ -- more

Data from Brentuximab Vedotin (SGN-35) Pivotal Phase II Trial in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Published in the Journal of Clinical Oncology

23rd May 2012 ZURICH, May 23, 2012 /PRNewswire/ -- more

HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure

23rd May 2012 more
RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
23rd May 2012 - Widespread Availability of MicroRNA Research Tools could Reduce the Opportunities for the Services Sector

Takeda Announces the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 Diabetes
23rd May 2012 LONDON and OSAKA, Japan, May 23, 2012 /PRNewswire/ --

Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
23rd May 2012

Promising Phase II Data With Once-Daily Tiotropium may Lead to New Treatment Option for Adolescent Asthma Patients
23rd May 2012 BRACKNELL, England, May 23, 2012 /PRNewswire/ --

Hunting PLC Donates $100,000 To New Danville
23rd May 2012

Once-Daily Epilepsy Treatment now Available in Sweden
23rd May 2012 HATFIELD, England, May 23, 2012 /PRNewswire/ --

Phase 3 Study Shows Efficacy is Maintained With lisdexamfetamine dimesylate (LDX) in Children and Adolescents With ADHD After at Least 6 Months of Treatment
23rd May 2012 NYON, Switzerland, May 23, 2012 /PRNewswire/ --

New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
23rd May 2012 LONDON, May 23, 2012 /PRNewswire/ --

Frost & Sullivan's Big Predictions for the Chemicals, Materials and Food Industry in 2012
23rd May 2012 - The four Mega Trends of low carbon economy, health and wellness, functionality and performance, and globalisation will shape these markets

Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
22nd May 2012 - The Echo® liquid handler that leverages the company's core acoustic technology is set to revolutionize liquid handling

Harper Government Leads an International Roundtable on Mental Health
22nd May 2012 GENEVA, Switzerland, May 22, 2012 /PRNewswire/ --

Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
22nd May 2012

AMRI Announces President for AMRI Europe
22nd May 2012

Frost & Sullivan: Spiralling Procedures and Budgetary Pressures Motivate Uptake of Custom Procedure Trays and Packs
22nd May 2012 - Move towards Standardisation and Minimisation of Non-essential Components to Help Manufacturers Sustain Growth

US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through India
22nd May 2012 - Joint Venture with Bangalore Headquartered Manipal Group Leverages Mobile Health Revolution in India to Commercialize Everist's New Cardiovascular Diagnostics

New Report From 112 Business Leaders Calls for Government to Pick Winning Technologies and Sectors to Drive Innovation-led Growth in the UK
22nd May 2012 LONDON, May 22, 2012 /PRNewswire/ --

ABPI and Teenage Cancer Trust CEOs in Keynote Debate at Patient Summit 2012
22nd May 2012 LONDON, May 22, 2012 /PRNewswire/ --

Volcano's Proprietary iFR® Functionality Demonstrates Excellent Results in Presentations at EuroPCR 2012
21st May 2012

Light-Responsive Melanopsin Found in Many Parts of the Human Brain
21st May 2012 OULU, Finland, May 21, 2012 /PRNewswire/ --

Chiltern Wins CRO Leadership Award From Life Science Leader
21st May 2012

Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama
21st May 2012 PANAMA CITY, Panama, May 21, 2012 /PRNewswire/ --

Global Guideline Could Help to Improve Dietary Intakes of Whole Grain in Young People
21st May 2012 LAUSANNE, Switzerland, May 21, 2012 /PRNewswire/ --

Study Results of Novocure's NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
21st May 2012

Fostering People Ireland Announces Recruitment Events
21st May 2012 BROMSGROVE, England, May 21, 2012 /PRNewswire/ --

ISJ Calls on EU's High Representative to Visit Camp Liberty and Recognize it as a Refugee Camp
21st May 2012 BRUSSELS, May 21, 2012 /PRNewswire/ --

Promus Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in Platinum Small Vessel Study
21st May 2012 NATICK, Massachusetts, May 21, 2012 /PRNewswire/ --

Aushon to Launch New Multiplex Immunoassay Platform
21st May 2012

Harper Government Supports Universal Health Care and Advances Mental Health at the World Health Assembly
21st May 2012 GENEVA, May 21, 2012 /PRNewswire/ --

Health Robotics' i.v.STATION Robot Receives Prestigious INDUSTRIESPREIS 2012 Award for Medical Devices
21st May 2012 BOZEN, Sud-Tirol, Italy, May 21, 2012 /PRNewswire/ --

Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
21st May 2012 NEW YORK, May 21, 2012 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that an abstract highlighting the dose related increases in iron storage parameters as observed...

Blood Matters: For the 17th Year, Thousands of Hematologists Meet in Amsterdam, June 14-17, 2012
21st May 2012 AMSTERDAM, May 21, 2012 /PRNewswire/ --

Exercising and Dieting Not Enough to Stop UK Obesity Freight Train - Dr Berardi
21st May 2012 BRADFORD, England, May 21, 2012 /PRNewswire/ --

Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
21st May 2012 MUNICH, May 21, 2012 /PRNewswire/ --

Gary Lineker, Jayne Torvill and Other Celebrities Back 'Team Give Blood' Campaign
21st May 2012 LONDON, May 21, 2012 /PRNewswire/ --

R&D Trends 2012 - Pharmaceutical Companies use Externalization & Collaboration to Drive Growth
21st May 2012 DALLAS, May 21, 2012 /PRNewswire/ --

PneumRx, Inc. Acquires Key Assets From Broncus
21st May 2012

Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
20th May 2012

Health Union Launches Mobile App, Migraine Meter to Help Patients Better Monitor and Manage Migraines
18th May 2012 PHILADELPHIA, May 18, 2012 /PRNewswire/ --

Health Canada - Notice to Media
18th May 2012 OTTAWA, May 18, 2012 /PRNewswire/ --

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting
18th May 2012 BEERSE, Belgium, May 18, 2012 /PRNewswire/ --

Arqule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-small Cell Lung Cancer
18th May 2012 WOBURN, Massachusetts and TOKYO, May 18, 2012 /PRNewswire/ --

The Multi - Factorial Equations of ART (Assisted Reproductive Technology): Defining and Maximizing Success in Pregnancy Rates
18th May 2012 SORRENTO, Italy, May 18, 2012 /PRNewswire/ --

Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late Breaking Clinical Trial Session at European Society of Cardiology 2012 Heart Failure Congress
18th May 2012 MONT-SAINT-GUIBERT, Belgium, May 18, 2012 /PRNewswire/ --

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us

(website) 47 queries took 275 ms
NrQueryErrorAffectedNum. rowsTook (ms)
1DESCRIBE `dms_releases`10101
2DESCRIBE `dms_categories`446
3DESCRIBE `dms_clinical_areas`441
4DESCRIBE `dms_categories_dms_releases`220
5DESCRIBE `dms_clinical_areas_dms_releases`2210
6DESCRIBE `dms_releases_sites`553
7DESCRIBE `dms_companies`26261
8DESCRIBE `press_release`13131
9DESCRIBE `company`27271
10DESCRIBE `condet`17171
11DESCRIBE `countrycode`440
12DESCRIBE `person`15151
13DESCRIBE `account`29291
14DESCRIBE `product_legacy`661
15DESCRIBE `sales_people`660
16DESCRIBE `profile`14141
17DESCRIBE `currencies`771
18DESCRIBE `update_rec`771
19DESCRIBE `user`24241
20DESCRIBE `enquiry`14141
21DESCRIBE `module_types`661
22DESCRIBE `licopp`23231
23DESCRIBE `development_statuses`551
24DESCRIBE `category`14141
25DESCRIBE `categories_sites`550
26DESCRIBE `categorisation`880
27DESCRIBE `licopps_sites`330
28DESCRIBE `service`15151
29DESCRIBE `story`12121
30DESCRIBE `sites_stories`550
31DESCRIBE `story_assoc`449
32DESCRIBE `companies_sites`331
33DESCRIBE `categories_users`220
34DESCRIBE `authority`330
35DESCRIBE `sites_users`551
36DESCRIBE `press_releases_sites`551
37DESCRIBE `newsml`991
38DESCRIBE `prnsubjects`440
39DESCRIBE `newsml_prnsubjects`220
40DESCRIBE `infDeviceNews`13131
41DESCRIBE `sites`550
42SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 1110
43SELECT `Newsml`.`id`, `Newsml`.`xml`, `Newsml`.`textdata`, `Newsml`.`summary`, `Newsml`.`headline`, `Newsml`.`RevisionCreated`, `Newsml`.`filename`, `Newsml`.`viewed_counter`, `Newsml`.`slug` FROM `newsml` AS `Newsml` WHERE 1 = 1 ORDER BY `Newsml`.`RevisionCreated` DESC LIMIT 505050112
44SELECT `Prnsubject`.`id`, `Prnsubject`.`code`, `Prnsubject`.`title`, `Prnsubject`.`slug`, `NewsmlPrnsubject`.`prnsubject_id`, `NewsmlPrnsubject`.`newsml_id` FROM `prnsubjects` AS `Prnsubject` JOIN `newsml_prnsubjects` AS `NewsmlPrnsubject` ON (`NewsmlPrnsubject`.`newsml_id` IN (9515, 9514, 9513, 9512, 9511, 9510, 9509, 9508, 9507, 9506, 9505, 9504, 9503, 9501, 9502, 9500, 9499, 9498, 9497, 9496, 9495, 9494, 9493, 9492, 9491, 9490, 9489, 9488, 9487, 9486, 9485, 9484, 9483, 9482, 9481, 9480, 9479, 9478, 9477, 9476, 9475, 9474, 9473, 9472, 9470, 9471, 9469, 9468, 9467, 9466) AND `NewsmlPrnsubject`.`prnsubject_id` = `Prnsubject`.`id`) 77772
45SELECT `Newsml`.`id`, `Newsml`.`headline`, `Newsml`.`slug`, `Newsml`.`RevisionCreated`, `Newsml`.`summary` FROM `newsml` AS `Newsml` WHERE 1 = 1 ORDER BY `viewed_counter` DESC, `RevisionCreated` DESC LIMIT 555106
46SELECT `Prnsubject`.`id`, `Prnsubject`.`code`, `Prnsubject`.`title`, `Prnsubject`.`slug`, `NewsmlPrnsubject`.`prnsubject_id`, `NewsmlPrnsubject`.`newsml_id` FROM `prnsubjects` AS `Prnsubject` JOIN `newsml_prnsubjects` AS `NewsmlPrnsubject` ON (`NewsmlPrnsubject`.`newsml_id` IN (1241, 556, 2355, 2432, 847) AND `NewsmlPrnsubject`.`prnsubject_id` = `Prnsubject`.`id`) 10101
47SELECT DISTINCT prnsubjects.id, prnsubjects.title, prnsubjects.slug FROM prnsubjects JOIN newsml_prnsubjects ON prnsubjects.id=newsml_prnsubjects.prnsubject_id WHERE title != ""ORDER BY title 58581